ArticleFrontiers in veterinary science2025
Genetic evolution, epidemic trends, and recombination dynamics of PRRSV-1 in China.
Article in Frontiers in veterinary science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Pathogenicity and virulence of PRRSV: From regulated cell death reprogramming landscape and immune subversion to precision vaccinology.Virulence · 2026Review
- Development and Application of a Triplex RT-qPCR Assay for Differentiating Major Lineages of Porcine Reproductive and Respiratory Syndrome Virus.Animals : an open access journal from MDPI · 2026Article
- Isolation, Genomic Characterization and Pathogenicity of a European-Like PRRSV-1 Strain in Newborn Piglets from Southwestern China.Veterinary sciences · 2026Article
- Comparative epidemiology and preparedness for African swine fever and porcine reproductive and respiratory syndrome in four major Asian swine industries.Frontiers in veterinary science · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The persistent threat of porcine reproductive and respiratory syndrome virus (PRRSV) to the global swine industry is exacerbated by the virus's high mutation rate and frequent recombination events. In China, the emergence of new PRRSV-1 strains in recent years has posed a significant challenge to the sustainability of pork production. This study systematically investigated the epidemiological patterns, genetic evolution, recombination dynamics, GP5 genetic diversity, and N-glycosylation variants of PRRSV-1 strains circulating in China. Whole-genome analysis demonstrated that Chinese PRRSV-1 isolates clustered within subtype 1, with BJEU06-1-like as the predominant subgroup and NMEU09-1-like as the secondary subgroup. Novel subgroups (new subgroups 1, 2, and 3), a new strain, GD2022, and an independent branch represented by strain GXFS20220129 were concurrently identified. High genetic diversity existed both within and between subgroups of Chinese PRRSV-1 strains. Whole-genome recombination has predominantly occurred through inter-subgroup exchange, primarily involving the BJEU06-1-like and Amervac-like lineages. Additionally, recombination events were identified between the field strain NVDC-FJ and the vaccine strain PRRSV1-CN-FJFQ-1-2023. Interestingly, the diversity of the ORF5 gene was consistent with that of the whole genome; however, there is a deviation in the phylogenetic tree position (BJEU06-1-like: 22 vs. 16). To understand the differences between ORF5 and whole-genome variations, we analyzed amino acid and glycosylation sites of the GP5 protein encoded by ORF5. The results indicated that mutations had occurred at amino acid sites within the antigenic epitopes and functional domains of GP5. Additionally, the prediction of potential N-glycosylation sites identified five locations in GP5: positions 35, 37, 38, 46, and 53. Alterations at these sites could facilitate immune evasion. Our analysis of the ORF5 gene suggests that PRRSV-1 research should not focus solely on ORF5 but rather must consider whole-genome variation, as this may provide insights for vaccine development. In summary, whole-genome studies of PRRSV-1 demonstrated that major recombinant subgroups and genetic evolution align with the current prevalence of BJEU06-1-like strains in China. Analysis of GP5 encoded by ORF5 confirmed the presence of differences between whole-genome and ORF5 data, exhibiting minor discrepancies in both the phylogenetic trees and the level of genetic diversity. Thus, instead of focusing solely on specific regions, whole-genome studies are needed to effectively track variation in PRRSV. This study fills a knowledge gap in our understanding of the prevalence and genetic variation of PRRSV-1 in China, providing crucial insights for developing PRRS control strategies and offering theoretical support for vaccine development.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.